HomeCompareOCDX vs ORCC

OCDX vs ORCC: Dividend Comparison 2026

OCDX yields 11.34% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCDX wins by $20.9K in total portfolio value
10 years
OCDX
OCDX
● Live price
11.34%
Share price
$17.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.3K
Annual income
$2,306.36
Full OCDX calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — OCDX vs ORCC

📍 OCDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCDXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCDX + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCDX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCDX
Annual income on $10K today (after 15% tax)
$964.27/yr
After 10yr DRIP, annual income (after tax)
$1,960.41/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, OCDX beats the other by $1,959.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCDX + ORCC for your $10,000?

OCDX: 50%ORCC: 50%
100% ORCC50/50100% OCDX
Portfolio after 10yr
$31.9K
Annual income
$1,153.70/yr
Blended yield
3.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

OCDX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCDX buys
0
ORCC buys
0
No recent congressional trades found for OCDX or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCDXORCC
Forward yield11.34%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$42.3K$21.4K
Annual income after 10y$2,306.36$1.04
Total dividends collected$17.1K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: OCDX vs ORCC ($10,000, DRIP)

YearOCDX PortfolioOCDX Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$11,834$1,134.43$11,190$489.61+$644.00OCDX
2$13,918$1,254.70$12,229$256.01+$1.7KOCDX
3$16,271$1,379.03$13,216$130.74+$3.1KOCDX
4$18,916$1,506.73$14,207$66.02+$4.7KOCDX
5$21,878$1,637.13$15,234$33.17+$6.6KOCDX
6$25,179$1,769.55$16,317$16.62+$8.9KOCDX
7$28,845$1,903.31$17,468$8.32+$11.4KOCDX
8$32,901$2,037.77$18,695$4.16+$14.2KOCDX
9$37,377$2,172.31$20,006$2.08+$17.4KOCDX
10$42,300$2,306.36$21,407$1.04+$20.9KOCDX

OCDX vs ORCC: Complete Analysis 2026

OCDXStock

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Full OCDX Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this OCDX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCDX vs SCHDOCDX vs JEPIOCDX vs OOCDX vs KOOCDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.